BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

BMEDvsFTXHETF Comparison

ETF 1

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

-1.76%

Full BMED fund page

VS

ETF 2

FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of

US Health Care

-0.99%

Full FTXH fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, FTXH's top sector exposures are Healthcare. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.6% for FTXH. BMED is up 14.51% year-to-date (YTD) with +$5M in YTD flows. FTXH performs better with 27.11% YTD performance, and +$1.01B in YTD flows. Run a side-by-side ETF comparison of BMED and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

BMED vs FTXH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/16/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	BMED FTXH	+3.05%+2.19%	+12.16%+8.28%	+14.51%+27.11%	+24.44%+45.11%	+54.98%+67.72%	+20.00%+75.07%
Flows	BMED FTXH	-+$34M	+$1M+$982M	+$5M+$1.01B	+$6M+$1.01B	+$7M+$1.01B	+$6M+$1.01B

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	BMED FTXH	+21.82%+18.80%	+17.81%+17.38%	+16.86%+17.15%	+18.13%+16.43%
Max drawdown	BMED FTXH	-5.85%-5.45%	-14.71%-7.50%	-19.76%-19.32%	-32.14%-19.32%
Max drawdown duration	BMED FTXH	31d52d	196d99d	237d393d	1479d393d

Trading data

Create an account to view trading data

Join for free

	BMED	FTXH
Last sale 10/16/2026 at 6:23 PM	$34.55	$41.65
Previous close 10/16/2026	$35.06	$41.97
Consolidated volume 10/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	BMED	FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/16/2026 at 6:23 PM

Live

Closed

	BMED	FTXH
Last price	$34.55	$41.65
1D performance	-1.45%	-0.76%
AuM	$13.83 M	$1.11 B
E/R	0.77%	0.6%

Characteristics

	BMED	FTXH
Management strategy	Active	Passive
Provider	iShares	First Trust
Benchmark	-	NASDAQ US Smart Pharmaceuticals Index
N° of holdings	53	49
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	September 29, 2020	September 20, 2016
ESG	No	No

More BMED data on Trackinsight

More FTXH data on Trackinsight

Exposure

Countries

BMED

USA

87.23%

Other

12.77%

FTXH

USA

95.82%

Other

4.18%

Sectors

BMED

Healthcare

98.95%

Other

1.05%

FTXH

Healthcare

99.79%

Other

0.21%

Diversification

BMED

Total weight of top 15 holdings out of 15

58.7%

FTXH

Total weight of top 15 holdings out of 15

67.15%

Top 15 holdings

Data as of August 31, 2026

BMED

Gilead Sciences, Inc.

5.01%

Merck & Co., Inc.

4.99%

AbbVie, Inc.

4.61%

Johnson & Johnson

4.27%

Charles River Laboratories International, Inc.

4.22%

Thermo Fisher Scientific, Inc.

4.12%

Edwards Lifesciences Corp.

3.95%

Moderna, Inc.

3.86%

IQVIA Holdings, Inc.

3.72%

Danaher Corp.

3.64%

Vertex Pharmaceuticals, Inc.

3.56%

Waters Corp.

3.53%

Biogen, Inc.

3.45%

Mettler-Toledo International, Inc.

3.16%

DexCom, Inc.

2.61%

FTXH

Merck & Co., Inc.

7.62%

AbbVie, Inc.

7.05%

Eli Lilly & Co.

6.92%

Johnson & Johnson

6.87%

Bristol Myers Squibb Co.

6.75%

Amgen, Inc.

3.56%

Biogen, Inc.

3.54%

Viatris, Inc.

3.51%

Vertex Pharmaceuticals, Inc.

3.48%

Regeneron Pharmaceuticals, Inc.

3.33%

Cardinal Health, Inc.

3.29%

Pfizer Inc.

3.25%

Gilead Sciences, Inc.

3.16%

Incyte Corp.

2.43%

United Therapeutics Corp.

2.39%

Frequently asked questions about BMED and FTXH

How have the BMED and FTXH ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while FTXH has returned 27.11%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or FTXH?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$1.01B for FTXH.

Which ETF is more volatile: BMED or FTXH?

Over the past year, BMED had a volatility of 17.81%, while FTXH experienced 17.38%.

Which ETF is bigger: BMED or FTXH?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while FTXH manages $1.11 B.

What sectors do the BMED and FTXH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the BMED ETF and FTXH ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. FTXH holds in its top three: Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co..

BMEDvsFTXHETF Comparison

iShares Health Innovation Active ETF

First Trust Nasdaq Pharmaceuticals ETF

BMED vs FTXH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the BMED and FTXH ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while FTXH has returned 27.11%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or FTXH?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$1.01B for FTXH.

Which ETF is more volatile: BMED or FTXH?

Over the past year, BMED had a volatility of 17.81%, while FTXH experienced 17.38%.

Which ETF is bigger: BMED or FTXH?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while FTXH manages $1.11 B.

What sectors do the BMED and FTXH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the BMED ETF and FTXH ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. FTXH holds in its top three: Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co..

Which ETF is more diversified: BMED or FTXH?

BMED holds 55 securities with 58.7% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 67.15%.

ETFs’ Next Act: From Access to Selection